Status:
COMPLETED
The Role of Oxidative Stress in the Cardiovascular Consequences of Sleep Apnea
Lead Sponsor:
Rami Khayat
Conditions:
Sleep Apnea
Eligibility:
All Genders
18+ years
Brief Summary
Obstructive Sleep Apnea (OSA) is the most common sleep disorder affecting up to 9-24 percent of middle aged adults, and is becoming increasingly implicated in the pathogenesis of hypertension, and oth...
Detailed Description
Obstructive Sleep Apnea (OSA) is increasingly recognized as a cardiovascular risk factor. OSA is a cause of hypertension and has strong association with atherosclerosis, coronary heart disease, diabet...
Eligibility Criteria
Inclusion
- Completed sleep study - Older than 18
Exclusion
- Hypertension
- Diabetes
- coronary disease
- Peripheral vascular disease
- High cholesterol
- Smoking
- Pregnancy
- Use of erectile dysfunction medications or supplements
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00701441
Start Date
February 1 2007
End Date
June 1 2010
Last Update
October 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43212